MedPath
NMPA Approval

Clopidogrel Bisulfate Tablets

H20150257

May 20, 2020

H20150257

Drug Information

硫酸氢氯吡格雷片

片剂

300mg(按C16H16ClNO2S计)

化学药品

May 20, 2020

May 19, 2025

Company Information

Applicant Company

82 avenue Raspail, 94250 Gentilly, France

Manufacturing Company

1 rue de la Vierge, Ambares&Lagrave, F-33565 Carbon Blanc Cedex, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫酸氢氯吡格雷片 - NMPA 批准文号 | MedPath